Surein returned to Australia in early 2022 after spending 2 years as a Post-Doctoral Research Fellow under the supervision of Prof Pasi Jänne at the Dana-Farber Cancer Center and Harvard Medical School in Boston, USA. His research is focused on understanding and developing novel strategies to manage minimal residual disease in oncogene-driven lung cancers.
He has a special interest in thoracic malignancies and is the associate editor for the Journal of Thoracic Oncology Clinical Research Reports published by the IASLC.
He has published over 25 peer-reviewed manuscripts, been an invited speaker both nationally and internationally and has been successful at competitive grant funding.
